Sign In
Buy CVS
$98.32
-0.84 (-0.85%)
At Close: Jun 18, 2026
Investors in CVS Health Corporation Should Contact Levi & Korsinsky Before September 10, 2024 to Discuss Your Rights - CVS
03:00pm, Monday, 15'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 15, 2024 / If you suffered a loss on your CVS Health Corporation (NYSE:CVS) investment and want to learn about a potential recovery under the federal securities laws,
LOS ANGELES, CA / ACCESSWIRE / July 15, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVS Health Corpor
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against CVS Health Corporation (CVS)
12:20pm, Monday, 15'th Jul 2024
NEW YORK, July 15, 2024 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of N
NEW YORK, NY / ACCESSWIRE / July 14, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against CVS Health Corporation ("CVS" or the "Company") (NYSE:CVS) and certain officers.
Investors Of CVS Health Corporation Are Urged To Participate In The Schall Law Firm's Probe Into Certain Claims
05:00pm, Saturday, 13'th Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVS Health Corpor
Pomerantz Law Firm Announces the Filing of a Class Action Against CVS Health Corporation and Certain Officers – CVS
08:13pm, Friday, 12'th Jul 2024
NEW YORK, July 12, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against CVS Health Corporation (“CVS” or the “Company”) (NYSE: CVS) and certain o
CVS Health Corporation Investors Are Encouraged To Join The Schall Law Firm's Investigation Into Specific Allegations
06:00pm, Friday, 12'th Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVS Health Corpor
CVS Health (CVS) Is Considered a Good Investment by Brokers: Is That True?
10:31am, Friday, 12'th Jul 2024
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
3 Healthcare Stocks to Buy Now to Profit From Aging Population Trends
03:45pm, Thursday, 11'th Jul 2024
If you can count, you may find healthcare stocks focused on the aging population to be a compelling opportunity. What do I mean?
The Schall Law Firm Is Investigating Specific Claims Against CVS Health Corporation And Urges Its Investors To Join
02:00pm, Thursday, 11'th Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVS Health Corpor
Top 4 Must-Have Healthcare Stocks for Long-Term Growth
11:11am, Thursday, 11'th Jul 2024
The healthcare industry represents a substantial and dynamic market sector, presenting many opportunities for investors seeking long-term growth and stability. Factors such as the aging population, te
7 High-Yield Dividend Stocks to Buy and Hold Forever: July Edition
08:00am, Thursday, 11'th Jul 2024
Seven companies offer a safety net against market volatility and constant dividend payments for those looking for a stable source of income. High-yield dividend companies are particularly appealing in
3 Underdog Stocks Set to Skyrocket This Year
06:15am, Thursday, 11'th Jul 2024
The economy is picking up as we speak. Unemployment currently sits at 3.7%, close to pre-pandemic levels.
CVS Health (CVS) Stock Falls Amid Market Uptick: What Investors Need to Know
06:52pm, Wednesday, 10'th Jul 2024
In the closing of the recent trading day, CVS Health (CVS) stood at $57.53, denoting a -0.16% change from the preceding trading day.
FTC to sue drug middlemen CVS, UnitedHealth over insulin prices: report
05:01pm, Wednesday, 10'th Jul 2024
The agency plans to file lawsuits targeting the business practices related to rebates brokered with drug manufacturers, the Journal reported.
